Interleukin 10 (IL-10)-mediated Immunosuppression March-i induction regulates antigen presentation by macrophages but not Dendritic cells

Journal of Biological Chemistry

Volumn 290, Issue 45, 2015, Pages 27158-27167

  Mittal, Sharad K ^a   Cho, Kyung Jin ^a   Ishido, Satoshi ^b   Roche, Paul A ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; MACROPHAGES;

ANTIGEN PRESENTATION; CLASS II; DENDRITIC CELLS; DENDRITIC CELLS (DCS); INTERLEUKIN-10; MOLECULAR MECHANISM; UBIQUITIN LIGASES;

ANTIGENS;

CD40 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; UBIQUITIN PROTEIN LIGASE E3; UBIQUITIN PROTEIN LIGASE E3 MARCH I; UNCLASSIFIED DRUG; CD86 PROTEIN, MOUSE; HLA ANTIGEN CLASS 2; IL10 PROTEIN, MOUSE; LIPOPOLYSACCHARIDE; MARCH1 PROTEIN, MOUSE; OVALBUMIN; OVALBUMIN (325-339); PEPTIDE FRAGMENT; UBIQUITIN PROTEIN LIGASE;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; BIOACCUMULATION; BONE MARROW DERIVED DENDRITIC CELL; CD4+ T LYMPHOCYTE; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; GENE EXPRESSION REGULATION; IMMUNOREGULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UBIQUITINATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL DIFFERENTIATION; CYTOLOGY; DEFICIENCY; ENZYME INDUCTION; ENZYMOLOGY; FEMALE; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; KNOCKOUT MOUSE; MALE; METABOLISM; PHYSIOLOGY;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD86; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; DENDRITIC CELLS; DOWN-REGULATION; ENZYME INDUCTION; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNE TOLERANCE; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OVALBUMIN; PEPTIDE FRAGMENTS; UBIQUITIN-PROTEIN LIGASES;

EID: 84946781662     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.682708     Document Type: Article

References (39)

1. Itano, A. A., and Jenkins, M. K. (2003) Antigen presentation to naive CD4 T cells in the lymph node. Nat. Immunol. 4, 733-739.
2. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B., and Palucka, K. (2000) Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811.
3. Kawai, T., and Akira, S. (2006) TLR signaling. Cell Death Differ. 13, 816-825.
4. Schroder, K., Hertzog, P. J., Ravasi, T., and Hume, D. A. (2004) Interferon-: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75, 163-189.
5. Matsuki, Y., Ohmura-Hoshino, M., Goto, E., Aoki, M., Mito-Yoshida, M., Uematsu, M., Hasegawa, T., Koseki, H., Ohara, O., Nakayama, M., Toyooka, K., Matsuoka, K., Hotta, H., Yamamoto, A., and Ishido, S. (2007) Novel regulation ofMHCclass II function in B cells.EMBOJ. 26, 846-854.
6. Ohmura-Hoshino, M., Matsuki, Y., Mito-Yoshida, M., Goto, E., Aoki- Kawasumi, M., Nakayama, M., Ohara, O., and Ishido, S. (2009) Cutting edge: requirement of MARCH-I-mediated MHC II ubiquitination for the maintenance of conventional dendritic cells. J. Immunol. 183, 6893-6897.
7. Ishido, S., Goto, E., Matsuki, Y., and Ohmura-Hoshino, M. (2009) E3 ubiquitin ligases for MHC molecules. Curr. Opin. Immunol. 21, 78-83.
8. De Gassart, A., Camosseto, V., Thibodeau, J., Ceppi, M., Catalan, N., Pierre, P., and Gatti, E. (2008) MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation. Proc. Natl. Acad. Sci. U.S.A. 105, 3491-3496.
9. Walseng, E., Furuta, K., Goldszmid, R. S., Weih, K. A., Sher, A., and Roche, P. A. (2010) Dendritic cell activation preventsMHCclass II ubiquitination and promotes MHC class II survival regardless of the activation stimulus. J. Biol. Chem. 285, 41749-41754.
10. Walseng, E., Furuta, K., Bosch, B., Weih, K. A., Matsuki, Y., Bakke, O., Ishido, S., and Roche, P. A. (2010) Ubiquitination regulates MHC class II-peptide complex retention and degradation in dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 107, 20465-20470.
11. Corcoran, K., Jabbour, M., Bhagwandin, C., Deymier, M. J., Theisen, D. L., and Lybarger, L. (2011) Ubiquitin-mediated regulation of CD86 protein expression by the ubiquitin ligase membrane-associated RING-CH-1 (MARCH1). J. Biol. Chem. 286, 37168-37180.
12. Roche, P. A., and Furuta, K. (2015) The ins and outs of MHC class IImediated antigen processing and presentation. Nat. Rev. Immunol. 15, 203-216.
13. Saraiva, M., and O'Garra, A. (2010) The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10, 170-181.
14. Mittal, S. K., and Roche, P. A. (2015) Suppression of antigen presentation by IL-10. Curr. Opin. Immunol. 34, 22-27.
15. Hunt, D., Wilson, J. E., Weih, K. A., Ishido, S., Harton, J. A., Roche, P. A., and Drake, J. R. (2012) Francisella tularensis elicits IL-10 via a PGE2- inducible factor, to drive macrophage MARCH1 expression and class II down-regulation. PLoS One 7, e37330.
16. Thibodeau, J., Bourgeois-Daigneault, M. C., Huppé, G., Tremblay, J., Au-mont, A., Houde, M., Bartee, E., Brunet, A., Gauvreau, M. E., de Gassart, A., Gatti, E., Baril, M., Cloutier, M., Bontron, S., Früh, K., Lamarre, D., and Steimle, V. (2008) Interleukin-10-induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes. Eur. J. Immunol. 38, 1225-1230.
17. Haase, C., Jørgensen, T. N., and Michelsen, B. K. (2002) Both exogenous and endogenous interleukin-10 affects the maturation of bone-marrowderived dendritic cells in vitro and strongly influences T-cell priming in vivo. Immunology 107, 489-499.
18. Avdic, S., Cao, J. Z., McSharry, B. P., Clancy, L. E., Brown, R., Steain, M., Gottlieb, D. J., Abendroth, A., and Slobedman, B. (2013) Human cytomegalovirus interleukin-10 polarizes monocytes toward a deactivated M2c phenotype to repress host immune responses. J. Virol. 87, 10273-10282.
19. Tze, L. E., Horikawa, K., Domaschenz, H., Howard, D. R., Roots, C. M., Rigby, R. J., Way, D. A., Ohmura-Hoshino, M., Ishido, S., Andoniou, C. E., Degli-Esposti, M. A., and Goodnow, C. C. (2011) CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation. J. Exp. Med. 208, 149-165.
20. Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S., and Steinman, R. M. (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176, 1693-1702.
21. Lévesque, S. A., Kukulski, F., Enjyoji, K., Robson, S. C., and Sévigny, J. (2010) NTPDase1 governs P2X7-dependent functions in murine macrophages. Eur. J. Immunol. 40, 1473-1485.
22. Schrum, A. G., Palmer, E., and Turka, L. A. (2005) Distinct temporal programming of naive CD4- T cells for cell division versus TCR-dependent death susceptibility by antigen-presenting macrophages. Eur. J. Immunol. 35, 449-459.
23. Young, L. J., Wilson, N. S., Schnorrer, P., Proietto, A., ten Broeke, T., Matsuki, Y., Mount, A. M., Belz, G. T., O'Keeffe, M., Ohmura-Hoshino, M., Ishido, S., Stoorvogel, W., Heath, W. R., Shortman, K., and Villadangos, J. A. (2008) Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells. Nat. Immunol. 9, 1244-1252.
24. Walseng, E., Bakke, O., and Roche, P. A. (2008) Major histocompatibility complex class II-peptide complexes internalize using a clathrin- And dynamin-independent endocytosis pathway. J. Biol. Chem. 283, 14717-14727.
25. Koppelman, B., Neefjes, J. J., de Vries, J. E., and de Waal Malefyt, R. (1997) Interleukin-10 down-regulates MHC class II - peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. Immunity 7, 861-871.
26. Vremec, D., O'Keeffe, M., Wilson, A., Ferrero, I., Koch, U., Radtke, F., Scott, B., Hertzog, P., Villadangos, J., and Shortman, K. (2011) Factors determining the spontaneous activation of splenic dendritic cells in culture. Innate Immun. 17, 338-352.
27. Chang, J., Kunkel, S. L., and Chang, C. H. (2009) Negative regulation of MyD88-dependent signaling by IL-10 in dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 106, 18327-18332.
28. Lee, S. J., Qin, H., and Benveniste, E. N. (2007) Simvastatin inhibits IFN- -induced CD40 gene expression by suppressing STAT-1-. J. Leukoc. Biol. 82, 436-447.
29. Li, J., Colovai, A. I., Cortesini, R., and Suciu-Foca, N. (2000) Cloning and functional characterization of the 5-regulatory region of the human CD86 gene. Hum. Immunol. 61, 486-498.
30. Koerner, T. J., Hamilton, T. A., and Adams, D. O. (1987) Suppressed expression of surface Ia on macrophages by lipopolysaccharide: evidence for regulation at the level of accumulation of mRNA. J. Immunol. 139, 239-243.
31. Curtale, G., Mirolo, M., Renzi, T. A., Rossato, M., Bazzoni, F., and Locati, M. (2013) Negative regulation of Toll-like receptor 4 signaling by IL-10- dependent microRNA-146b. Proc. Natl. Acad. Sci. U.S.A. 110, 11499-11504.
32. McCoy, C. E., Sheedy, F. J., Qualls, J. E., Doyle, S. L., Quinn, S. R., Murray, P. J., and O'Neill, L. A. (2010) IL-10 inhibits miR-155 induction by toll-like receptors. J. Biol. Chem. 285, 20492-20498.
33. An, H., Xu, H., Zhang, M., Zhou, J., Feng, T., Qian, C., Qi, R., and Cao, X. (2005) Src homology 2 domain-containing inositol-5-phosphatase 1 (SHIP1) negatively regulates TLR4-mediated LPS response primarily through a phosphatase activity- And PI-3K-independent mechanism. Blood 105, 4685-4692.
34. Gabhann, J. N., Higgs, R., Brennan, K., Thomas, W., Damen, J. E., Ben Larbi, N., Krystal, G., and Jefferies, C. A. (2010) Absence of SHIP-1 results in constitutive phosphorylation of tank-binding kinase 1 and enhanced TLR3-dependent IFN- production. J. Immunol. 184, 2314-2320.
35. de Waal Malefyt, R., Haanen, J., Spits, H., Roncarolo, M. G., te Velde, A., Figdor, C., Johnson, K., Kastelein, R., Yssel, H., and de Vries, J. E. (1991) Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific humanTcell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174, 915-924.
36. Ding, Y., Chen, D., Tarcsafalvi, A., Su, R., Qin, L., and Bromberg, J. S. (2003) Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses. J. Immunol. 170, 1383-1391.
37. Chattopadhyay, G., and Shevach, E. M. (2013) Antigen-specific induced T regulatory cells impair dendritic cell function via an IL-10/MARCH1-dependent mechanism. J. Immunol. 191, 5875-5884.
38. Kalinski, P., Schuitemaker, J. H., Hilkens, C. M., and Kapsenberg, M. L. (1998) Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a-CD83- dendritic cells: The levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation. J. Immunol. 161, 2804-2809.
39. Pajkrt, D., Camoglio, L., Tiel-van Buul, M. C., de Bruin, K., Cutler, D. L., Affrime, M. B., Rikken, G., van der Poll, T., ten Cate, J. W., and van Deventer, S. J. (1997) Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administration. J. Immunol. 158, 3971-3977.